These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29126984)

  • 21. Deletion of OPN in BSP knockout mice does not correct bone hypomineralization but results in high bone turnover.
    Bouleftour W; Juignet L; Verdière L; Machuca-Gayet I; Thomas M; Laroche N; Vanden-Bossche A; Farlay D; Thomas C; Gineyts E; Concordet JP; Renaud JB; Aubert D; Teixeira M; Peyruchaud O; Vico L; Lafage-Proust MH; Follet H; Malaval L
    Bone; 2019 Mar; 120():411-422. PubMed ID: 30529011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinated regulation and colocalization of alphav integrin and its activating enzyme proprotein convertase PC5 in vivo.
    Stawowy P; Graf K; Goetze S; Roser M; Chrétien M; Seidah NG; Fleck E; Marcinkiewicz M
    Histochem Cell Biol; 2003 Mar; 119(3):239-45. PubMed ID: 12649739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PC1/3, PC2 and PC5/6A are targeted to dense core secretory granules by a common mechanism.
    Dikeakos JD; Mercure C; Lacombe MJ; Seidah NG; Reudelhuber TL
    FEBS J; 2007 Aug; 274(16):4094-102. PubMed ID: 17645548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin.
    Narisawa S; Yadav MC; Millán JL
    J Bone Miner Res; 2013 Jul; 28(7):1587-98. PubMed ID: 23427088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia.
    Hoac B; Østergaard M; Wittig NK; Boukpessi T; Buss DJ; Chaussain C; Birkedal H; Murshed M; McKee MD
    J Bone Miner Res; 2020 Oct; 35(10):2032-2048. PubMed ID: 32501585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model.
    Sun X; Essalmani R; Seidah NG; Prat A
    Mol Cancer; 2009 Sep; 8():73. PubMed ID: 19737405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knock-out mouse models of proprotein convertases: unique functions or redundancy?
    Creemers JW; Khatib AM
    Front Biosci; 2008 May; 13():4960-71. PubMed ID: 18508561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinases of cultured osteoblasts: selectivity for the extracellular matrix proteins of bone and their catalytic competence for osteopontin.
    Salih E; Ashkar S; Gerstenfeld LC; Glimcher MJ
    J Bone Miner Res; 1996 Oct; 11(10):1461-73. PubMed ID: 8889846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
    Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
    Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA‑338‑3p regulates age‑associated osteoporosis via targeting PCSK5.
    Tong J; Zhang M; Li X; Ren G
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin is highly susceptible to cleavage in bovine milk and the proteolytic fragments bind the αVβ₃-integrin receptor.
    Christensen B; Sørensen ES
    J Dairy Sci; 2014; 97(1):136-46. PubMed ID: 24268404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.
    Higashibata Y; Sakuma T; Kawahata H; Fujihara S; Moriyama K; Okada A; Yasui T; Kohri K; Kitamura Y; Nomura S
    J Bone Miner Res; 2004 Jan; 19(1):78-88. PubMed ID: 14753740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis.
    Stawowy P; Kallisch H; Borges Pereira Stawowy N; Stibenz D; Veinot JP; Gräfe M; Seidah NG; Chrétien M; Fleck E; Graf K
    Virchows Arch; 2005 Apr; 446(4):351-9. PubMed ID: 15756593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin mediates mineralization and not osteogenic cell development in vitro.
    Holm E; Gleberzon JS; Liao Y; Sørensen ES; Beier F; Hunter GK; Goldberg HA
    Biochem J; 2014 Dec; 464(3):355-64. PubMed ID: 25310312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal regulation of proprotein convertase subtilisin/kexin type 5 expression during ovarian follicle development in the rat.
    Bae JA; Park HJ; Seo YM; Roh J; Hsueh AJ; Chun SY
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):29-37. PubMed ID: 18502031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice.
    Harmey D; Johnson KA; Zelken J; Camacho NP; Hoylaerts MF; Noda M; Terkeltaub R; Millán JL
    J Bone Miner Res; 2006 Sep; 21(9):1377-86. PubMed ID: 16939396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The developmental expression in the rat CNS and peripheral tissues of proteases PC5 and PACE4 mRNAs: comparison with other proprotein processing enzymes.
    Zheng M; Seidah NG; Pintar JE
    Dev Biol; 1997 Jan; 181(2):268-83. PubMed ID: 9013936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo.
    Morinobu M; Ishijima M; Rittling SR; Tsuji K; Yamamoto H; Nifuji A; Denhardt DT; Noda M
    J Bone Miner Res; 2003 Sep; 18(9):1706-15. PubMed ID: 12968681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice.
    Yuan Q; Jiang Y; Zhao X; Sato T; Densmore M; Schüler C; Erben RG; McKee MD; Lanske B
    J Bone Miner Res; 2014 Mar; 29(3):693-704. PubMed ID: 24038141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone sialoprotein, but not osteopontin, deficiency impairs the mineralization of regenerating bone during cortical defect healing.
    Monfoulet L; Malaval L; Aubin JE; Rittling SR; Gadeau AP; Fricain JC; Chassande O
    Bone; 2010 Feb; 46(2):447-52. PubMed ID: 19761880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.